Pharmaceutical Executive Europe - August 2008 - (Page 22) 22 Last Words August 2008 Pharmaceutical Executive Europe “The highest possible ethical standards are required by the pharmaceutical industry in all its activities. Breaches of the Code are viewed seriously and this is reflected by the suspension.” — Chris Brinsmead, president of the Association of the British Pharmaceutical Industry, on its suspension of Roche UK. Last Words… The month in pharma, according to industry leaders, regulators and commentators. “This is the first realistic evidence that a new drug can slow cognition decline in people with Alzheimer's, by targeting the protein tangles that cause brain cell death.” — The UK Alzheimer’s Society, on TaurX’s drug-in-development, Rember. “[Our internal audits] will demonstrate that no data manipulation, fraud, or dishonesty occurred.” — Ranbaxy, answering accusations of data fraud made by the US government. “As we've always made clear, 2008 was going to be a year with a number of swing factors associated with it and some of those are still to come.” GSK head Andrew Witty on his plan for costcutting and product re-focusing “We believe we are paying a fair price for a very good company with a great strategic rationale, which will provide benefits for many years to come." Teva CEO Shlomo Yanai on his company’s takeover of US rival, Barr. “All parties continue to work hard in good faith on an orderly, documented and objective process that examines each claim to determine if individuals are qualified to receive a payment.” Bruce Kuhlik, Merck & Co’s general counsel, on the company’s imminent pay-out to Vioxx claimants.
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - August 2008 Pharmaceutical Executive Europe - August 2008 Contents From the Editor News and Analysis Calendar The Calm Before the Storm Steering Pharma in Russia Built on Sand Renaissance Man IT Meets IMI Send for the Software Specialists Know Your eMarket Last Words Pharmaceutical Executive Europe - August 2008 Pharmaceutical Executive Europe - August 2008 - Pharmaceutical Executive Europe - August 2008 (Page Cover1) Pharmaceutical Executive Europe - August 2008 - Pharmaceutical Executive Europe - August 2008 (Page Cover2) Pharmaceutical Executive Europe - August 2008 - Contents (Page 3) Pharmaceutical Executive Europe - August 2008 - Contents (Page 4) Pharmaceutical Executive Europe - August 2008 - From the Editor (Page 5) Pharmaceutical Executive Europe - August 2008 - News and Analysis (Page 6) Pharmaceutical Executive Europe - August 2008 - News and Analysis (Page 7) Pharmaceutical Executive Europe - August 2008 - Calendar (Page 8) Pharmaceutical Executive Europe - August 2008 - Calendar (Page 9) Pharmaceutical Executive Europe - August 2008 - The Calm Before the Storm (Page 10) Pharmaceutical Executive Europe - August 2008 - Steering Pharma in Russia (Page 11) Pharmaceutical Executive Europe - August 2008 - Built on Sand (Page 12) Pharmaceutical Executive Europe - August 2008 - Renaissance Man (Page 13) Pharmaceutical Executive Europe - August 2008 - Renaissance Man (Page 14) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 15) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 16) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 17) Pharmaceutical Executive Europe - August 2008 - Send for the Software Specialists (Page 18) Pharmaceutical Executive Europe - August 2008 - Send for the Software Specialists (Page 19) Pharmaceutical Executive Europe - August 2008 - Know Your eMarket (Page 20) Pharmaceutical Executive Europe - August 2008 - Know Your eMarket (Page 21) Pharmaceutical Executive Europe - August 2008 - Last Words (Page 22)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.